JP2024511066A - 不適応ストレス応答から生じる疾患を治療する改善された方法 - Google Patents

不適応ストレス応答から生じる疾患を治療する改善された方法 Download PDF

Info

Publication number
JP2024511066A
JP2024511066A JP2023557667A JP2023557667A JP2024511066A JP 2024511066 A JP2024511066 A JP 2024511066A JP 2023557667 A JP2023557667 A JP 2023557667A JP 2023557667 A JP2023557667 A JP 2023557667A JP 2024511066 A JP2024511066 A JP 2024511066A
Authority
JP
Japan
Prior art keywords
crfr2
agonist
maladaptation
ct38s
cfs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511066A5 (https=
Inventor
ジェラード ペレイラ
Original Assignee
コルティーン インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コルティーン インコーポレイテッド filed Critical コルティーン インコーポレイテッド
Publication of JP2024511066A publication Critical patent/JP2024511066A/ja
Publication of JP2024511066A5 publication Critical patent/JP2024511066A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP2023557667A 2021-03-17 2022-03-17 不適応ストレス応答から生じる疾患を治療する改善された方法 Pending JP2024511066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163200609P 2021-03-17 2021-03-17
US63/200,609 2021-03-17
PCT/US2022/071209 WO2022198230A1 (en) 2021-03-17 2022-03-17 Improved methods of treating diseases resulting from a maladapted stress response

Publications (2)

Publication Number Publication Date
JP2024511066A true JP2024511066A (ja) 2024-03-12
JP2024511066A5 JP2024511066A5 (https=) 2025-03-26

Family

ID=83320930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557667A Pending JP2024511066A (ja) 2021-03-17 2022-03-17 不適応ストレス応答から生じる疾患を治療する改善された方法

Country Status (6)

Country Link
US (1) US20250319161A1 (https=)
EP (1) EP4308150A4 (https=)
JP (1) JP2024511066A (https=)
AU (1) AU2022238570A1 (https=)
CA (1) CA3212248A1 (https=)
WO (1) WO2022198230A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117618528B (zh) * 2023-12-01 2024-10-01 广东医科大学 一种方格星虫多肽srp及其在制备治疗急性肾损伤药物中的应用
TW202544027A (zh) * 2024-04-19 2025-11-16 美商紐羅克里生物科學有限公司 促皮質素釋放因子受體２（ｃｒｆｒ２）促效劑

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019533021A (ja) * 2016-10-20 2019-11-14 コーティーン インコーポレイテッド 不適応のストレス応答に寄与する疾患を処置する方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110105397A1 (en) * 2009-11-04 2011-05-05 Gengo Peter J Method for treating heart failure with stresscopin-like peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019533021A (ja) * 2016-10-20 2019-11-14 コーティーン インコーポレイテッド 不適応のストレス応答に寄与する疾患を処置する方法

Also Published As

Publication number Publication date
CA3212248A1 (en) 2022-09-22
AU2022238570A1 (en) 2023-09-28
EP4308150A4 (en) 2025-02-19
US20250319161A1 (en) 2025-10-16
WO2022198230A1 (en) 2022-09-22
EP4308150A1 (en) 2024-01-24

Similar Documents

Publication Publication Date Title
US11963946B2 (en) MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin, or other psychedelics
EP2099468B1 (en) Methods of use of trk receptor modulators
CN106562952B (zh) 氯胺酮在治疗重性抑郁障碍中的应用
US11648295B2 (en) Methods of treating diseases resulting from a maladapted stress response
Rastogi et al. Novel treatment modalities for painful diabetic neuropathy
JP2024511066A (ja) 不適応ストレス応答から生じる疾患を治療する改善された方法
EP4547218A1 (en) Tirzepatide compositions and use
Wang et al. Selective activation of metabotropic glutamate receptor 7 blocks paclitaxel-induced acute neuropathic pain and suppresses spinal glial reactivity in rats
US8906357B2 (en) Treatment of multiple sclerosis with masitinib
US20240197756A1 (en) Methods of treatment with neuroactive steroids
US9861594B2 (en) Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
JP2023526517A (ja) 運動失調症を治療するためのアセチルロイシンと４－アミノピリジン又はアセタゾラミドとの組合せ
JP6567971B2 (ja) 女性性機能障害の治療におけるブレメラノチドの使用
WO2012170452A2 (en) Compositions and methods for treating neurodegenerative diseases
JP2020517648A (ja) 抗ｃｄ５２抗体を用いて多発性硬化症を処置するための経路およびスケジュール
JP7155116B2 (ja) 女性の性機能障害を治療する医薬組成物および方法
Chaithali A Study to Assess the Effect of Pretreatment with Intravenous Palonosetron in Preventing Pain on Propofol Injection
EP3233825A1 (en) Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
Class et al. Patent application title: TREATMENT OF MULTIPLE SCLEROSIS WITH MASITINIB Inventors: Alain Moussy (Paris, FR) Alain Moussy (Paris, FR) Jean-Pierre Kinet (Lexington, MA, US) Jean-Pierre Kinet (Lexington, MA, US) Assignees: AB SCIENCE
Class et al. Patent application title: METHODS TO REDUCE THE EFFECTS OF SLEEP DEPRIVATION Inventors: Samuel A. Deadwyler (Lewisville, NC, US) Robert E. Hampson (Kernersville, NC, US) Linda Porrino (Lewisville, NC, US) Michael Todd (Winston Salem, NC, US) Thomas N. Thannickal (Winnetka, CA, US) Yuan-Yan Lai (North Hills, CA, US) Jerome M. Siegel (Northridge, CA, US) Assignees: The US Government Respresented by the Department of Veterans Affairs
HK1209058B (en) Compositions for treating drug addiction and improving addiction-related behavior
HK1176285B (en) Compositions for treating drug addiction and improving addiction-related behavior
HK1176285A1 (en) Compositions for treating drug addiction and improving addiction-related behavior

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250317

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260402